Sarah Cannon Research Institute University of Oklahoma — Oklahoma City, Oklahoma

Sarah Cannon Research Institute University of Oklahoma is a clinical research site located in Oklahoma City, Oklahoma, United States 73104.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute University of Oklahoma has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC).

Sponsors: Phanes Therapeutics.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute University of Oklahoma?

Sarah Cannon Research Institute University of Oklahoma has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute University of Oklahoma conducted?

Sarah Cannon Research Institute University of Oklahoma has 2 clinical trials on record, with 2 currently active. Their work covers Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC).

Is Sarah Cannon Research Institute University of Oklahoma accredited by Crixeo Health?

Sarah Cannon Research Institute University of Oklahoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute University of Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.